Tachyarrhythmia

1

Review clinical trials related to Tachyarrhythmia. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

BIO|MASTER.CorSky Family Post-market Study for the CorSky Family of ICDs

The CorSky family is BIOTRONIK´s new generation of ICDs. They are the successor devices of the current Acticor/Rivacor family and inherit all iShock/iShock\_BC (Ilivia Neo, Intica Neo) implant and programmer software features. The new features of CorSky Family are either true novel BIOTRONIK ICD features or mainly driven by unification with the Amvia pacemaker family (Amvia Edge, -Sky). The goal of the study is to confirm the safety and performance of the CorSky Family of ICDs and CRT-Ds.

Participants needed: 151
Trial details
Age: 18-99Biological sex: AllType: ObservationalSponsor: Biotronik SE & Co. KGUpdated: Jul 10, 2026Locations: 7
Eligibility criteria

Standard indication for ICD or CRT-D therapy according to clinical guidelines [+4]

For VR-T DX and CRT-DX: Permanent atrial tachyarrhythmia [+7]